Literature DB >> 23055214

Photodynamic therapy and antitumor immunity.

Sandra O Gollnick1.   

Abstract

Preclinical studies have shown that local photodynamic therapy (PDT) enhances systemic antitumor immunity. In addition, it has long been known that the long-term efficacy of PDT depends on the presence of an intact adaptive immune system. Years of research in the laboratory have attempted to shed light on the mechanisms of the PDT-enhanced antitumor immune response, suggesting that increased expression of proinflammatory cytokines may play a key role. This overview on the immunologic potential of PDT briefly explores these proposed mechanisms and addresses preliminary results with PDT vaccines in combination with surgery as perhaps a new clinical strategy for cancer treatment outside the laboratory.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23055214      PMCID: PMC3683987          DOI: 10.6004/jnccn.2012.0173

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  8 in total

1.  Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo.

Authors:  S O Gollnick; X Liu; B Owczarczak; D A Musser; B W Henderson
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

2.  Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis.

Authors:  J Usuda; T Okunaka; K Furukawa; T Tsuchida; Y Kuroiwa; Y Ohe; N Saijo; K Nishio; C Konaka; H Kato
Journal:  Int J Cancer       Date:  2001-08-15       Impact factor: 7.396

3.  Generation of effective antitumor vaccines using photodynamic therapy.

Authors:  Sandra O Gollnick; Lurine Vaughan; Barbara W Henderson
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

Review 4.  Photodynamic therapy enhancement of anti-tumor immunity.

Authors:  Craig M Brackett; Sandra O Gollnick
Journal:  Photochem Photobiol Sci       Date:  2011-01-21       Impact factor: 3.982

Review 5.  Structure and signalling in the IL-17 receptor family.

Authors:  Sarah L Gaffen
Journal:  Nat Rev Immunol       Date:  2009-07-03       Impact factor: 53.106

6.  Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils.

Authors:  Philaretos C Kousis; Barbara W Henderson; Patricia G Maier; Sandra O Gollnick
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

7.  Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors.

Authors:  Barbara W Henderson; Sandra O Gollnick; John W Snyder; Theresa M Busch; Philaretos C Kousis; Richard T Cheney; Janet Morgan
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

8.  Enhanced systemic immune reactivity to a Basal cell carcinoma associated antigen following photodynamic therapy.

Authors:  Edith Kabingu; Allan R Oseroff; Gregory E Wilding; Sandra O Gollnick
Journal:  Clin Cancer Res       Date:  2009-06-23       Impact factor: 12.531

  8 in total
  20 in total

1.  Painless versus conventional photodynamic therapy for treatment of actinic keratosis: Comparison of cell death and immune response in a murine model.

Authors:  Sanjay Anand; Anton Yasinchak; Mukul Govande; Sajina Shakya; Edward V Maytin
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2019-02-28

2.  Ruthenium Photosensitizers for NIR PDT Require Lowest-Lying Triplet Intraligand (3IL) Excited States.

Authors:  Liubov M Lifshits; John A Roque; Elamparuthi Ramasamy; Randolph P Thummel; Colin G Cameron; Sherri A McFarland
Journal:  J Photochem Photobiol       Date:  2021-09-15

3.  Intraligand Excited States Turn a Ruthenium Oligothiophene Complex into a Light-Triggered Ubertoxin with Anticancer Effects in Extreme Hypoxia.

Authors:  John A Roque Iii; Houston D Cole; Patrick C Barrett; Liubov M Lifshits; Rachel O Hodges; Susy Kim; Gagan Deep; Antonio Francés-Monerris; Marta E Alberto; Colin G Cameron; Sherri A McFarland
Journal:  J Am Chem Soc       Date:  2022-04-28       Impact factor: 16.383

4.  Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433.

Authors:  Susan Monro; Katsuya L Colón; Huimin Yin; John Roque; Prathyusha Konda; Shashi Gujar; Randolph P Thummel; Lothar Lilge; Colin G Cameron; Sherri A McFarland
Journal:  Chem Rev       Date:  2018-10-08       Impact factor: 60.622

5.  Photodynamic therapy of human lung cancer xenografts in mice.

Authors:  Chukwumere Nwogu; Paula Pera; Wiam Bshara; Kristopher Attwood; Ravindra Pandey
Journal:  J Surg Res       Date:  2015-07-17       Impact factor: 2.192

6.  Bis[pyrrolyl Ru(ii)] triads: a new class of photosensitizers for metal-organic photodynamic therapy.

Authors:  Deborah A Smithen; Susan Monro; Mitch Pinto; John Roque; Roberto M Diaz-Rodriguez; Huimin Yin; Colin G Cameron; Alison Thompson; Sherri A McFarland
Journal:  Chem Sci       Date:  2020-10-06       Impact factor: 9.825

Review 7.  Boosting Tumor-Specific Immunity Using PDT.

Authors:  Nicole Maeding; Thomas Verwanger; Barbara Krammer
Journal:  Cancers (Basel)       Date:  2016-10-06       Impact factor: 6.639

Review 8.  Prospects in the Application of Photodynamic Therapy in Oral Cancer and Premalignant Lesions.

Authors:  Rajan Saini; Nathan V Lee; Kelly Y P Liu; Catherine F Poh
Journal:  Cancers (Basel)       Date:  2016-09-02       Impact factor: 6.639

9.  Tropomyosin Receptor Kinase C Targeted Delivery of a Peptidomimetic Ligand-Photosensitizer Conjugate Induces Antitumor Immune Responses Following Photodynamic Therapy.

Authors:  Chin Siang Kue; Anyanee Kamkaew; Siew Hui Voon; Lik Voon Kiew; Lip Yong Chung; Kevin Burgess; Hong Boon Lee
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

10.  NIR-Absorbing RuII Complexes Containing α-Oligothiophenes for Applications in Photodynamic Therapy.

Authors:  Liubov M Lifshits; John A Roque; Houston D Cole; Randolph P Thummel; Colin G Cameron; Sherri A McFarland
Journal:  Chembiochem       Date:  2020-09-25       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.